Re-treatment of patients with chronic hepatitis C virus genotype 4 infection with pegylated interferon and ribavirin: a meta-analysis

BACKGROUND: An estimated 170 million people worldwide are infected with hepatitis C virus (HCV). HCV genotype 4 (HCV-4)—the most prevalent hepatitis C strain in the Middle East and Africa—is difficult to treat, with an estimated sustained virological response (SVR) of 53% when using pegylated interf...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMJ Open Gastroenterol
Prif Awduron: Zhang, Bing, Nguyen, Nghia H, Yee, Brittany E, Yip, Benjamin, Nguyen, Mindie H
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2015
Pynciau:
Hepatology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4650907/
https://ncbi.nlm.nih.gov/pubmed/26629360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2015-000057
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg